Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review

BACKGROUND: Approximately 20% of patients with neuroendocrine tumours (NETs) develop carcinoid syndrome (CS), characterised by flushing and diarrhoea. Somatostatin analogues or telotristat can be used to control symptoms of CS through inhibition of serotonin secretion. Although CS is often the cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Mohid S, Walter, Thomas, Buchanan-Hughes, Amy, Worthington, Emma, Keeber, Lucie, Feuilly, Marion, Grande, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438200/
https://www.ncbi.nlm.nih.gov/pubmed/32874063
http://dx.doi.org/10.3748/wjg.v26.i30.4537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438200/
https://www.ncbi.nlm.nih.gov/pubmed/32874063
http://dx.doi.org/10.3748/wjg.v26.i30.4537

Ejemplares similares